G1 Therapeutics Inc
(GTHX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,137 | 19,950 | 32,281 | 52,686 | 55,977 |
| Marketable Securities | 45,656 | 45,299 | 49,938 | 41,729 | 48,317 |
| Receivables | 13,309 | 11,654 | 12,687 | 9,265 | 13,171 |
| Inventories | 13,383 | 12,548 | 12,442 | 13,491 | 15,600 |
| TOTAL | $92,922 | $95,839 | $114,948 | $126,103 | $140,436 |
| Non-Current Assets | |||||
| PPE Net | 1,235 | 1,355 | 1,476 | 1,600 | 1,727 |
| Other Non-Current Assets | 4,532 | 4,832 | 5,116 | 5,394 | 5,728 |
| TOTAL | $5,767 | $6,187 | $6,592 | $6,994 | $7,455 |
| Total Assets | $98,689 | $102,026 | $121,540 | $133,097 | $147,891 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,412 | 5,946 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,156 | 5,109 | 3,992 | 7,335 | 5,762 |
| Accrued Expenses | 17,081 | 17,867 | 21,893 | 24,181 | 24,681 |
| Other current liabilities | 2,906 | 3,285 | 3,211 | 1,451 | 3,326 |
| TOTAL | $37,504 | $32,603 | $29,716 | $33,653 | $33,912 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,906 | 37,147 | 51,557 | 51,246 | 50,936 |
| Deferred Revenues | 949 | 396 | 620 | 686 | 143 |
| Other Non-Current Liabilities | 3,687 | 4,037 | 4,381 | 4,676 | 4,995 |
| TOTAL | $36,593 | $41,684 | $56,438 | $56,422 | $56,431 |
| Total Liabilities | $74,097 | $74,287 | $86,154 | $90,075 | $90,343 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,758 | 52,281 | 52,199 | 51,844 | 51,746 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -795,673 | -790,204 | -779,985 | -769,107 | -750,903 |
| Other shareholders' equity | -8 | -8 | -8 | -8 | -8 |
| TOTAL | $24,592 | $27,739 | $35,386 | $43,022 | $57,548 |
| Total Liabilities And Equity | $98,689 | $102,026 | $121,540 | $133,097 | $147,891 |